BioTricity Inc. Reports Unregistered Equity Sales
Ticker: BTCY · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1630113
Sentiment: neutral
Topics: equity-sale, unregistered-securities
TL;DR
BioTricity sold unregistered shares on 6/4/24.
AI Summary
On June 4, 2024, BioTricity Inc. reported the unregistered sale of equity securities. The company, incorporated in Nevada, issued shares under the 1934 Act, with its principal executive offices located in Redwood City, California.
Why It Matters
This filing indicates BioTricity Inc. has issued equity securities without a prior registration, which could impact existing shareholders and the company's financial structure.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can sometimes signal financial distress or be used for capital raises that dilute existing shareholders.
Key Players & Entities
- BioTricity Inc. (company) — Registrant
- June 4, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- Redwood City, California (location) — Address of Principal Executive Offices
FAQ
What type of equity securities were sold?
The filing states "Unregistered Sales of Equity Securities" but does not specify the exact type of securities in the provided text.
What was the total dollar amount of the unregistered equity sale?
The provided text does not specify the dollar amount of the unregistered equity sale.
Who were the purchasers of these unregistered equity securities?
The filing does not disclose the identity of the purchasers of the unregistered equity securities.
What is the reason for the unregistered sale of equity securities?
The filing does not provide a specific reason for the unregistered sale of equity securities.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 4, 2024.
Filing Stats: 417 words · 2 min read · ~1 pages · Grade level 12.4 · Accepted 2024-06-07 16:34:44
Key Financial Figures
- $0.001 B — ch registered Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Indicate
Filing Documents
- form8-k.htm (8-K) — 32KB
- 0001493152-24-023126.txt ( ) — 201KB
- btcy-20240604.xsd (EX-101.SCH) — 3KB
- btcy-20240604_lab.xml (EX-101.LAB) — 33KB
- btcy-20240604_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: June 7, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer